7289 related articles for article (PubMed ID: 2461020)
1. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
2. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
Ito S; Wakamatsu K; Inoue S; Fujita K
Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
[TBL] [Abstract][Full Text] [Related]
3. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
[TBL] [Abstract][Full Text] [Related]
4. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Hansson C; Wirestrand LE; Aronsson A; Rorsman H; Rosengren E
Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of melanocytic metabolites in fertile women.
Carstam R; Hansson C; Rorsman H; Rosengren E; Sjöberg NO; Wirestrand LE
Acta Derm Venereol; 1985; 65(6):543-5. PubMed ID: 2420122
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid: differences between pigmented and albino mice.
Ekelund MC; Carstam R; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1985; 65(5):437-9. PubMed ID: 2416171
[TBL] [Abstract][Full Text] [Related]
8. Some indolic compounds as markers of the melanocyte activity.
Hansson C
Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
[TBL] [Abstract][Full Text] [Related]
9. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
Saito N; Morishima T
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
[TBL] [Abstract][Full Text] [Related]
10. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
Wakamatsu K; Ito S; Horikoshi T
Melanoma Res; 1991; 1(2):141-7. PubMed ID: 1823626
[TBL] [Abstract][Full Text] [Related]
11. Melanocyte metabolites in the urine of people of different skin colour.
Wirestrand LE; Hansson C; Rosengren E; Rorsman H
Acta Derm Venereol; 1985; 65(4):345-8. PubMed ID: 2413694
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of dopa in human albinism.
Carstam R; Hansson C; Krook G; Rorsman H; Rosengren E; Wirestrand LE
Acta Derm Venereol; 1985; 65(5):435-7. PubMed ID: 2416170
[TBL] [Abstract][Full Text] [Related]
13. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
Beyer C; Fiedler H; Wohlrab W; Wozniak KD
Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
[No Abstract] [Full Text] [Related]
16. Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.
Jimbow K; Miyake Y; Homma K; Yasuda K; Izumi Y; Tsutsumi A; Ito S
Cancer Res; 1984 Mar; 44(3):1128-34. PubMed ID: 6318981
[TBL] [Abstract][Full Text] [Related]
17. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
[TBL] [Abstract][Full Text] [Related]
18. Melanin-related metabolites as markers of the skin pigmentary system.
Westerhof W; Pavel S; Kammeyer A; Beusenberg FD; Cormane R
J Invest Dermatol; 1987 Jul; 89(1):78-81. PubMed ID: 3598203
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G
Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505
[TBL] [Abstract][Full Text] [Related]
20. 5-S-cysteinyldopa in the urine of melanoma patients.
Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
